Despite being the only person diagnosed with all three subtypes of pyoderma gangrenosum, Becker remains hopeful. "There’s no ...
The proprietary Invisicare delivery technology has exclusive rights for all orphan rare skin disease applications, enhancing Quoin's competitive advantage in the pharmaceutical market. The company ...
Steven Daniel Daveluy, MD, FAAD, discussed how artificial intelligence (AI) can leverage extensive patient data and guide dermatologists to improve early diagnosis and treatment of rare dermatological ...
Dilgen, a 22-year-old Tottenville resident, has been battling epidermolysis bullosa (EB), a rare, life-threatening genetic ...
Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), a biopharmaceutical company specializing in inflammation and immunology (I&I) ...
said the hospital has established a hereditary skin disease clinic to ensure the availability of long-term treatment for patients, including "butterfly children" and other rare disease sufferers.
Quoin is committed to advancing clinical testing for this product while seeking extensive patent protection for other rare skin disease treatments. The company emphasizes its dedication to ...
Target Indications Also Include Peeling Skin Syndrome, SAM Syndrome, Palmoplantar Keratoderma and Severe Atopic DermatitisThird Quoin Patent ...
Lower doses of a common antibiotic can curb hair loss caused by a rare skin condition ... COVID-19 linked to higher risk for autoimmune diseases like alopecia, Crohn's New medication may treat ...
we are also taking multiple steps to ensure that we have the broadest and most extensive patent protection around the product for this disease as well for other rare skin disease applications that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results